Takuya Suzuki
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Takuya Suzuki has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Kazuhisa Uemura
Department of Plastic and Reconstructive Surgery, Wakayama Medical University, Wakayama, Japan
2 shared publications Shinichi Asamura
2 shared publicationsGen Yamada
Department of Plastic and Reconstructive Surgery, Wakayama Medical University, Wakayama, Japan
1 shared publication- Gen Yamada
Department of Developmental Genetics, Wakayama Medical University
1 shared publication Hikaru Watanabe
1 shared publication- Katsuro Tachibana
Department of Anatomy, Faculty of Medicine, Fukuoka University, 7-45-1 Nanakuma, Jonan-ku, Fukuoka 814-0180, Japan
1 shared publication
Latest Publications
- Open Access
- 15 September 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 454-458
Quantitative assessment of lower eyelid morphology following orbital floor fracture repair
- 15 September 2026
- Published by Elsevier in JPRAS Open
- Vol. 52, 454-458
Open AccessQuantitative assessment of lower eyelid morphology following orbital floor fracture repair
- Open Access
- 18 October 2025
- Published by Elsevier in JPRAS Open
- Vol. 46, 703-711
Novel thermoplastic splint for treating congenital auricular deformities with late initiation of treatment
- 18 October 2025
- Published by Elsevier in JPRAS Open
- Vol. 46, 703-711
Open AccessNovel thermoplastic splint for treating congenital auricular deformities with late initiation of treatment
- Open Access
- 5 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 11883
Ultrasound Irradiation as a Candidate Procedure to Improve the Transdermal Drug Delivery to the Tail Edema of a Mouse Model
Drug therapy for secondary lymphedema has not yet been established. Conventional oral and intravenous administration is difficult to administer in sufficient doses due to adverse events. Therefore, it is necessary to develop a transdermal delivery system that can deliver high concentrations of drugs to the edema area. In this study, we examined the efficacy of transdermal drug delivery in a mouse model of tail edema using ultrasound irradiation (sonication method). Ultrasound irradiation can deliver high-molecular-weight substances subcutaneously, and the percutaneous administration of clobetasol propionate to the mouse tail edema model prevented the enlargement of lymphatic vessels with reduced tail volume. Therefore, steroid administration utilizing ultrasound irradiation is effective in decreasing tail swelling in a mouse tail edema model. Thus, ultrasound irradiation could have the potential to innovate the treatment of secondary lymphedema by directly administering the drug to the edema.
- 5 November 2024
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 25 (22) , 11883
Open AccessUltrasound Irradiation as a Candidate Procedure to Improve the Transdermal Drug Delivery to the Tail Edema of a Mouse Model
Drug therapy for secondary lymphedema has not yet been established. Conventional oral and intravenous administration is difficult to administer in sufficient doses due to adverse events. Therefore, it is necessary to develop a transdermal delivery system that can deliver high concentrations of drugs to the edema area. In this study, we examined the efficacy of transdermal drug delivery in a mouse model of tail edema using ultrasound irradiation (sonication method). Ultrasound irradiation can deliver high-molecular-weight substances subcutaneously, and the percutaneous administration of clobetasol propionate to the mouse tail edema model prevented the enlargement of lymphatic vessels with reduced tail volume. Therefore, steroid administration utilizing ultrasound irradiation is effective in decreasing tail swelling in a mouse tail edema model. Thus, ultrasound irradiation could have the potential to innovate the treatment of secondary lymphedema by directly administering the drug to the edema.